Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025MedicineOpen Access

Risk factors for mortality in febrile neutropenic patients treated with colistin

View Full Paper
Ask AI
Bookmark
Share

Authors

CYCumali YALÇINVÖVildan ÖzkocamanTETuba Ersal

Discussion

Loading...

Member takes

Overview

Analysis reveals mortality risks in febrile neutropenic patients treated with colistin, indicating timely intervention is crucial.

Key Points

  • Delaying colistin treatment after 5 days significantly increases the risk of mortality due to febrile neutropenia and sepsis.
  • Patients with sepsis or septic shock showed a hazard ratio of 5.02, emphasizing the impact of acute conditions on outcomes.
  • Isolated gram-negative bacteria like K. pneumoniae and A. baumannii were linked to higher mortality rates among culture-positive patients.
  • The presence of invasive pulmonary aspergillosis also increased mortality risk, underscoring the need for rapid treatment initiation.

Cite This Study

YALÇIN et al. (2025) studied this question.

synapsesocial.com/papers/68de79685b556a9128e1a983https://doi.org/10.1097/md.0000000000044841
View Full Paper
Ask AI
Bookmark
Share